If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
31st Mar 20149:41 amRNSHuntsworth plc Notice of Preliminary Results
13th Dec 20137:00 amRNSAtomic merges with Grayling
2nd Dec 20139:37 amRNSBlocklisting Interim Review
2nd Dec 20139:34 amRNSTotal Voting Rights
28th Nov 20133:55 pmRNSAdditional Listing
13th Nov 20137:00 amRNSInterim Management Statement
8th Nov 201311:29 amRNSDirector/PDMR Shareholding
5th Nov 201312:40 pmRNSAdditional Listing
1st Nov 20139:51 amRNSTotal Voting Rights
25th Oct 20134:19 pmRNSHolding(s) in Company - Replacement
25th Oct 20132:09 pmRNSHolding(s) in Company
23rd Oct 20134:40 pmRNSHolding(s) in Company
15th Oct 20134:35 pmRNSPrice Monitoring Extension
14th Oct 20139:45 amRNSHolding(s) in Company
11th Oct 201311:27 amRNSHolding(s) in Company
10th Oct 201312:45 pmRNSTotal Voting Rights
9th Oct 201312:20 pmRNSScrip Dividend Alternative
7th Oct 20138:22 amRNSCompletion of Subscription & Director Appointment
4th Oct 201311:05 amRNSResult of GM
30th Sep 20135:14 pmRNSDirector/PDMR Shareholding
18th Sep 20134:12 pmRNSPublication of Prospectus
21st Aug 20134:22 pmRNSUpdate on proposed investment
9th Aug 20133:00 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNSInterim results for the six months to 30 June 2013
1st Aug 201310:57 amRNSTotal Voting Rights
29th Jul 20132:30 pmRNSNotice of results & update on proposed investment
5th Jul 201311:56 amRNSDirector/PDMR Shareholding
3rd Jul 20131:38 pmRNSAdditional Listing
1st Jul 20139:38 amRNSTotal Voting Rights
28th Jun 201311:37 amRNSHolding(s) in Company
26th Jun 20134:15 pmRNSTreasury Stock
26th Jun 201311:26 amRNSHolding(s) in Company
24th Jun 20137:00 amRNSHuntsworth to appoint first CEO for Asia-Pacific
20th Jun 20134:56 pmRNSAdditional Listing
13th Jun 201311:38 amRNSResult of AGM
5th Jun 201312:05 pmRNSScrip Dividend Alternative
3rd Jun 20131:15 pmRNSBlocklisting Interim Review
17th May 20137:00 amRNSInterim Management Statement
14th May 20139:43 amRNSNotice of AGM
2nd May 201311:03 amRNSHolding(s) in Company
1st May 20138:56 amRNSTotal Voting Rights
30th Apr 20135:31 pmRNSAnnual Financial Report
29th Apr 20131:38 pmRNSTreasury Stock
26th Apr 20135:34 pmRNSHolding(s) in Company
26th Apr 20132:26 pmRNSDirector/PDMR Shareholding
25th Apr 20138:39 amRNSReplacement: Final Results
25th Apr 20137:01 amRNSBLUEFOCUS TO INVEST £36.5m in HUNTSWORTH
25th Apr 20137:00 amRNSFinal Results
4th Apr 20137:00 amRNSNotice of Results
5th Feb 20137:00 amRNSPre-Close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.